Quest Diagnostics Is Now Selling Biological Age: What the $29 Test Actually Measures
Humanity's biological age test is now a $29 add-on at 2,000 Quest locations. The model behind it tracked 306,000+ people for 11.6 years and covers six body systems.
Function Health's AI Connector: Your Lab Results Just Became AI Training Data — For You
Function's new connector links 160+ personal lab results to ChatGPT, Claude, and Perplexity. Over 80% of members have at least one biomarker outside optimal range — now AI can reason over that directly.
GDF-15 and P-Tau217: The Biomarkers That Warn You Before You Feel Anything
New biomarker research is shifting the question from 'what's wrong?' to 'what's coming?' GDF-15 as a cellular stress signal and p-tau217 for pre-symptomatic Alzheimer's risk represent a new category of early detection — but their limitations matter as much as their promise.
GDF-15 and P-tau217: The Biomarkers That Signal Breakdown Before You Feel It
Two biomarkers — GDF-15 for cellular stress and P-tau217 for Alzheimer's risk — can flag physiological strain years before symptoms appear. Here's what they measure, what trends reveal, and why a single reading misses the point.
Blood Filtering Is the New Wellness Flex — And Viome Just Bought the Infrastructure
Viome's acquisition of Circulate Health pairs multi-omics biomarker testing with therapeutic plasma exchange. What this convergence means for longevity-focused consumers navigating an increasingly clinical wellness stack.
NMR Blood Testing: One Blood Sample, Four Different Risk Scores
A single NMR blood scan reveals heart disease, insulin resistance, inflammation, and mortality risk — the inventor explains why one draw beats a standard panel.
Fountain Life's $595 BASE Plan Is the Longevity Industry's Mass-Market Moment
Fountain Life's new BASE membership brings 100+ biomarkers, DEXA scan, and AI-guided clinician review to individuals for $595 — a significant shift from its ultra-premium roots.
SystemAge 2.1: The First Biological Age Test with Separate Male and Female Models
Generation Lab's SystemAge 2.1 analyzes 460+ biomarkers across 21 organ systems using gender-specific algorithms — the most granular biological age measurement now available through clinical partners.
Peter Attia: High HDL Cholesterol Doesn't Protect Your Heart. It Might Hurt It.
HDL-C has been called 'good cholesterol' for decades. Peter Attia's latest analysis unpacks why the clinical evidence never supported the label — and why very high HDL-C levels may signal elevated cardiovascular risk, not lower.
Ultrahuman M2 Live Makes Continuous Glucose Monitoring Mainstream
Ultrahuman's M2 Live pairs with Abbott's OTC Lingo CGM to bring prescription-free glucose tracking to anyone for $99/month — removing the biggest barrier to metabolic health monitoring.
Alamar's Dried Blood Spot Kit Makes Hospital-Grade Proteomics Work on a Fingerstick at Home
Alamar Biosciences' NULISA DBS Extraction Kit extends proximity ligation proteomics to dried blood spot samples—85–95% detectability, compatible with Capitainer and Mitra devices, ships standard mail.
InsideTracker Pivots to AI Platform: What the Terra Shift Means for Biohacking
InsideTracker is becoming Terra, a B2B AI platform licensing biomarker-based health guidance to wellness and healthcare companies. The consumer brand isn't gone — it's becoming infrastructure.
Plasma Exchange Cuts Blood Microplastics by 60%: First Clinical Data
A May 2026 study in the Journal of Clinical Apheresis found therapeutic plasma exchange reduced blood microplastic levels from 52.2 to 21.1 particles per 100µL — the first peer-reviewed data on clinically removing microplastics from circulation.
At-Home Finger-Prick Test Hits 86% Accuracy for Alzheimer's
Nature Medicine validated at-home p-tau217 finger-prick sampling at 86% accuracy. Here's what it means for early Alzheimer's detection.
Function Buys SuppCo: What Independent Supplement Testing Really Reveals
Function.health acquires SuppCo to add ISO-verified supplement testing to its 160-test biomarker platform. The backstory: roughly half of top-selling supplements fail their own label claims.
Function Health: The Case for Testing Insulin Before You Need To
Function Health offers 160+ lab tests covering metabolic and hormonal markers that standard care skips — here's what the extra data actually tells you.
GRAIL's Trial Missed Its Endpoint. That's Not the Same as Failing.
Peter Attia's analysis of GRAIL's landmark cancer screening trial: a missed composite endpoint doesn't tell you whether multi-cancer early detection technology works.